Activaero raises €10.7m for breathing device development

29 Oct 2009

Activaero, a German developer of controlled breathing technologies for inhaled therapeutic agents has received €10.7m of series A venture financing. The round was led by BioMed Partners, a Swiss healthcare and life sciences-focused venture firm, and included VI Partners, Abalis Finance and Vesalius Biocapital.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.

NEWS & VIEWS

Global private equity and venture capital news and research

By News Type

By PE Sector

By Region

By Region

Country Focus

PE Focus

Industry Focus

Other

AltAssets Events

Industry Events